http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101900989-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101900989-B1
titleOfInvention Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
abstract The invention week 41 as a dopamine D 1 and D 2 receptors, for the treatment of disorders of the central nervous system to the dose plan as having activity at serotonin 5HT 2 receptors - ((1R, 3S) -6- chloro-3 -Phenyl-indan-1-yl) -1,2,2-trimethyl-piperazine and salts thereof.
priorityDate 2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010037398-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11465618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414868843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3693574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592315

Total number of triples: 47.